The cross-priming pathway: a portrait of an intricate immune system (Q36770431)

16 August 2017

1 reference

title

The cross-priming pathway: a portrait of an intricate immune system (English)

1 reference

16 August 2017

Basta S

1

1 reference

PubMed ID

17386021

16 August 2017

Alatery A

series ordinal

2

1 reference

16 August 2017

1 April 2007

1 reference

Scandinavian Journal of Immunology

16 August 2017

1 reference

16 August 2017

65

1 reference

16 August 2017

4

1 reference

16 August 2017

311-319

1 reference

Processing and presentation of antigens by dendritic cells: implications for vaccines

16 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Clinical implications of antigen transfer mechanisms from malignant to dendritic cells. exploiting cross-priming.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Understanding presentation of viral antigens to CD8+ T cells in vivo: the key to rational vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Priming of T cells by exogenous antigen cross-presented on MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Cytotoxic T lymphocyte activation by cross-priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Antigen presentation to CD8+ T cells: cross-priming in infectious diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Mini‐review: Regulation of cytotoxic T lymphocyte responses by dendritic cells: peaceful coexistence of cross‐priming and direct priming?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Dendritic cells: specialized and regulated antigen processing machines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Translational control of viral gene expression in eukaryotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Not such a dismal science: the economics of protein synthesis, folding, degradation and antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

The impact of misfolding versus targeted degradation on the efficiency of the MHC class I-restricted antigen processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Protein degradation and the generation of MHC class I-presented peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Post-proteasomal antigen processing for major histocompatibility complex class I presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Introduction of soluble protein into the class I pathway of antigen processing and presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Cross-presentation of the long-lived lymphocytic choriomeningitis virus nucleoprotein does not require neosynthesis and is enhanced via heat shock proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Reversal in the immunodominance hierarchy in secondary CD8+ T cell responses to influenza A virus: roles for cross-presentation and lysis-independent immunodomination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

CD8+ T cell cross-priming via transfer of proteasome substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Cross-priming of CD8+ T cells by viral and tumor antigens is a robust phenomenon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Heat-aggregated noninfectious influenza virus induces a more balanced CD8(+)-T-lymphocyte immunodominance hierarchy than infectious virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and -independent pathways of antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Macrophages and dendritic cells use the cytosolic pathway to rapidly cross-present antigen from live, vaccinia-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Toll-like receptor 3 promotes cross-priming to virus-infected cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Induction of antigen cross-presentation by Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

MyD88 expression is required for efficient cross-presentation of viral antigens from infected cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Viral interference with antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Inhibitory effects of cytomegalovirus proteins US2 and US11 point to contributions from direct priming and cross-priming in induction of vaccinia virus-specific CD8(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

A Survival Game of Hide and Seek: Cytomegaloviruses and MHC Class I Antigen Presentation Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Murine cytomegalovirus interference with antigen presentation has little effect on the size or the effector memory phenotype of the CD8 T cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Direct priming and cross-priming contribute differentially to the induction of CD8+ CTL following exposure to vaccinia virus via different routes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

CpG-DNA aided cross-priming by cross-presenting B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Exogenous antigens gain access to the major histocompatibility complex class I processing pathway in B cells by receptor-mediated uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Neutrophils process exogenous bacteria via an alternate class I MHC processing pathway for presentation of peptides to T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Cross-priming as a predominant mechanism for inducing CD8(+) T cell responses in gene gun DNA immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Immune complex-loaded dendritic cells are superior to soluble immune complexes as antitumor vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Constitutive versus activation-dependent cross-presentation of immune complexes by CD8(+) and CD8(-) dendritic cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Activation of dendritic cells: translating innate into adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Liver sinusoidal endothelial cells are insufficient to activate T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Liver sinusoidal endothelial cells that endocytose allogeneic cells suppress T cells with indirect allospecificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Antigen presentation by the endothelium: a green light for antigen-specific T cell trafficking?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Mouse endothelial cells cross-present lymphocyte-derived antigen on class I MHC via a TAP1- and proteasome-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

A blast from the past: clearance of apoptotic cells regulates immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Both dendritic cells and macrophages can stimulate naive CD8 T cells in vivo to proliferate, develop effector function, and differentiate into memory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Immature monocytes acquire antigens from other cells in the bone marrow and present them to T cells after maturing in the periphery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Phagosomes are competent organelles for antigen cross-presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Monocyte and macrophage heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Life cycle, migration and antigen presenting functions of spleen and lymph node dendritic cells: limitations of the Langerhans cells paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Priming of CTLs by lymphocytic choriomeningitis virus depends on dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Cutting Edge: Conventional CD8α+ Dendritic Cells Are Preferentially Involved in CTL Priming After Footpad Infection with Herpes Simplex Virus-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Cutting edge: conventional CD8 alpha+ dendritic cells are generally involved in priming CTL immunity to viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

CD8alpha- CD11b+ dendritic cells present exogenous virus-like particles to CD8+ T cells and subsequently express CD8alpha and CD205 molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Antitumor monoclonal antibodies enhance cross-presentation ofcCellular antigens and the generation of myeloma-specific killer T cells by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Dendritic cells acquire antigens from live cells for cross-presentation to CTL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Cross-presentation of cell-associated antigens by CD8alpha+ dendritic cells is attributable to their ability to internalize dead cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Immune activation: death, danger and dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Death-defying immunity: do apoptotic cells influence antigen processing and presentation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Herpes simplex virus infection of human dendritic cells induces apoptosis and allows cross-presentation via uninfected dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Essay 1: the Danger model in its historical context

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Cellular protein is the source of cross-priming antigen in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

The mannose receptor mediates uptake of soluble but not of cell-associated antigen for cross-presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Antigen bias in T cell cross-priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Cross-priming utilizes antigen not available to the direct presentation pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Cross-presentation of Listeria-derived CD8 T cell epitopes requires unstable bacterial translation products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Cutting edge: cross-presentation of cell-associated antigens to MHC class I molecule is regulated by a major transcription factor for heat shock proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Hyperthermia enhances CTL cross-priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

The many roads to cross-presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Peptides chaperoned by heat-shock proteins are a necessary and sufficient source of antigen in the cross-priming of CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Re-evaluating the role of heat-shock protein-peptide interactions in tumour immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Loading of MHC class I and II presentation pathways by exogenous antigens: a quantitative in vivo comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Macrophages use different internalization mechanisms to clear apoptotic and necrotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Cutting Edge: Intravenous Soluble Antigen Is Presented to CD4 T Cells by CD8- Dendritic Cells, but Cross-Presented to CD8 T Cells by CD8+ Dendritic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

Cell-Associated Ovalbumin Is Cross-Presented Much More Efficiently than Soluble Ovalbumin In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01909.X

10.1111/J.1365-3083.2007.01909.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17386021